<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wiegand A</submitter><funding>Deutsche Forschungsgemeinschaft</funding><funding>German Federal Ministry of Education and Research (BMBF)</funding><pagination>10840</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12652996</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>26(22)</volume><pubmed_abstract>Alcohol use disorder (AUD) is associated with widespread epigenetic alterations, including changes in DNA methylation (DNAm). This multi-cohort study validated and extended previous findings on DNAm of &lt;i>HECW2&lt;/i> and &lt;i>GDAP1&lt;/i> in AUD, assessed sex differences, and explored DNAm in blood and brain tissue in humans and rats. DNAm was measured via pyrosequencing in human blood (N&lt;sub>Ctrl&lt;/sub> = 341, N&lt;sub>AUD&lt;/sub> = 258), postmortem frontal cortex (Brodmann area 9; discovery cohort: N&lt;sub>Ctrl&lt;/sub> = 10, N&lt;sub>AUD&lt;/sub> = 13, replication cohort: N&lt;sub>Ctrl&lt;/sub> = 64, N&lt;sub>AUD&lt;/sub> = 55) and rat blood and medial prefrontal cortex (N&lt;sub>Ctrl&lt;/sub> = 16, N&lt;sub>AUD&lt;/sub> = 15). Gene expression was assessed in human postmortem brain by quantitative real-time PCR. AUD-associated DNAm d</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Validation of &amp;lt;i&amp;gt;GDAP1&amp;lt;/i&amp;gt; and &amp;lt;i&amp;gt;HECW2&amp;lt;/i&amp;gt; as Epigenetic Markers of Alcohol Use Disorder in Blood and Brain.</pubmed_title><pmcid>PMC12652996</pmcid><funding_grant_id>NI13332/13-1</funding_grant_id><funding_grant_id>01ZX01909</funding_grant_id><funding_grant_id>TRR265</funding_grant_id><pubmed_authors>Koller G</pubmed_authors><pubmed_authors>Friske M</pubmed_authors><pubmed_authors>Zill P</pubmed_authors><pubmed_authors>Hansson AC</pubmed_authors><pubmed_authors>Nieratschker V</pubmed_authors><pubmed_authors>Wiegand A</pubmed_authors><pubmed_authors>Edelmann S</pubmed_authors><pubmed_authors>Sommer WH</pubmed_authors><pubmed_authors>Bakalkin G</pubmed_authors><pubmed_authors>Fischer L</pubmed_authors><pubmed_authors>Bender A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Validation of &amp;lt;i&amp;gt;GDAP1&amp;lt;/i&amp;gt; and &amp;lt;i&amp;gt;HECW2&amp;lt;/i&amp;gt; as Epigenetic Markers of Alcohol Use Disorder in Blood and Brain.</name><description>Alcohol use disorder (AUD) is associated with widespread epigenetic alterations, including changes in DNA methylation (DNAm). This multi-cohort study validated and extended previous findings on DNAm of &lt;i>HECW2&lt;/i> and &lt;i>GDAP1&lt;/i> in AUD, assessed sex differences, and explored DNAm in blood and brain tissue in humans and rats. DNAm was measured via pyrosequencing in human blood (N&lt;sub>Ctrl&lt;/sub> = 341, N&lt;sub>AUD&lt;/sub> = 258), postmortem frontal cortex (Brodmann area 9; discovery cohort: N&lt;sub>Ctrl&lt;/sub> = 10, N&lt;sub>AUD&lt;/sub> = 13, replication cohort: N&lt;sub>Ctrl&lt;/sub> = 64, N&lt;sub>AUD&lt;/sub> = 55) and rat blood and medial prefrontal cortex (N&lt;sub>Ctrl&lt;/sub> = 16, N&lt;sub>AUD&lt;/sub> = 15). Gene expression was assessed in human postmortem brain by quantitative real-time PCR. AUD-associated DNAm d</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-05-19T03:14:02.324Z</modification><creation>2026-05-19T03:10:38.449Z</creation></dates><accession>S-EPMC12652996</accession><cross_references><pubmed>41303328</pubmed><doi>10.3390/ijms262210840</doi></cross_references></HashMap>